Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during

Xiaoming Yang1, Marpe Bam1, Prakash S Nagarkatti1

  • 1Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina Columbia, South Carolina, 29209, USA.

Scientific Reports
|November 2, 2019
PubMed

Insights

Cannabidiol (CBD) treatment suppresses inflammation in a multiple sclerosis (MS) model by altering gene expression and histone modifications in immune cells. This immune modulation involves changes in transcription factors, miRNAs, and lncRNAs.

Area of Science:

  • Immunology
  • Neuroscience
  • Epigenetics

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Cannabidiol (CBD) has demonstrated potential in attenuating experimental autoimmune encephalomyelitis (EAE), an animal model for MS.
  • The molecular mechanisms underlying CBD's therapeutic effects in EAE remain incompletely understood.

Purpose of the Study:

  • To investigate the genome-wide effects of CBD on histone modifications and gene expression in lymphocytes from MOG-sensitized EAE mice.
  • To identify specific epigenetic changes and gene expression patterns modulated by CBD treatment.
  • To explore the role of transcription factors, miRNAs, and lncRNAs in CBD-mediated immune modulation.

Main Methods:

  • ChIP-seq was employed to compare H3K4me3 and H3K27me3 histone marks in CD4+ T cells from naïve, EAE, and CBD-treated EAE mice.
  • Microarray analysis was used to assess genome-wide gene expression profiles.
  • Next-generation sequencing (NGS) was utilized to analyze miRNA and lncRNA expression.

Main Results:

  • CBD treatment altered the signal intensity and coverage of H3K4me3 and H3K27me3 marks at specific genes, suggesting modulation of gene expression via histone modification.
  • Histone methylation signals were differentially enriched at the binding sites of transcription factors like ZNF143 and FoxA1.
  • CBD treatment reversed the expression patterns of many EAE-induced genes and significantly affected the expression of numerous miRNAs and lncRNAs.

Conclusions:

  • CBD suppresses inflammation in the EAE model through multifaceted mechanisms involving epigenetic modifications and regulation of gene expression.
  • CBD's action involves altering histone methylation patterns, influencing transcription factor binding, and modulating the expression of non-coding RNAs (miRNAs and lncRNAs).
  • These findings provide novel insights into the molecular pathways targeted by CBD for immune modulation in the context of MS.